Advanced search
Companies (178)
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (neb ...
Capitalization | 12 201 M USD |
---|---|
Change | -0.11% |
1-year price change | +24.81% |
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination ant ...
Capitalization | 9 166 M USD |
---|---|
Change | +4.52% |
1-year price change | +90.71% |
Hon Kwok Land Investment Company, Limited is a Hong Kong-based investment holding company principally engaged in property businesses. The Company operates through three segments. The Property Development segment is engaged in property development. The Pro ...
Capitalization | 151 M USD |
---|---|
Change | -0.61% |
1-year price change | +16.31% |
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), refe ...
Capitalization | 8 307 M USD |
---|---|
Change | +0.65% |
1-year price change | -23.87% |
bioAffinity Technologies, Inc. is a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease. The Company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of ...
Capitalization | 27 M USD |
---|---|
Change | -1.96% |
1-year price change | +54.37% |
Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical ...
Capitalization | 7 457 M USD |
---|---|
Change | +0.14% |
1-year price change | -16.26% |
Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solut ...
Capitalization | 40 M USD |
---|---|
Change | -1.67% |
1-year price change | -25.32% |
Biodesix, Inc. (Biodesix) is a diagnostic solutions and services company. The Company develops diagnostic tests addressing clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers over five Medicare-covered ...
Capitalization | 193 M USD |
---|---|
Change | +7.52% |
1-year price change | -22.83% |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bi ...
Capitalization | 5 419 M USD |
---|---|
Change | +1.81% |
1-year price change | +201.53% |
Neola Medical AB, formerly GPX Medical AB is a Sweden-based company that is involved in development of medical instruments. The Company's business concept is to commercialize the Company's medical technology product for continuous lung monitoring based on ...
Capitalization | 18 M USD |
---|---|
Change | -3.01% |
1-year price change | +32.31% |
Synairgen plc is a United Kingdom-based holding company for Synairgen Research Limited, which is a respiratory drug discovery and development company. The Company is developing SNG001, an investigative formulation of inhaled interferon beta (IFN-B), for t ...
Capitalization | 17 M USD |
---|---|
Change | -6.31% |
1-year price change | +4.44% |
ImmunoGen, Inc. is a commercial-stage biotechnology company. The Company is focused on developing and commercializing of antibody- drug conjugates (ADCs) to improve outcomes for cancer patients. An ADC with the Company's technology comprises an antibody t ...
Capitalization | 8 359 M USD |
---|---|
Change | -.--% |
1-year price change | +5.33% |
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions i ...
Capitalization | 4 M USD |
---|---|
Change | -.--% |
1-year price change | -100.00% |
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritin ...
Capitalization | 6 471 M USD |
---|---|
Change | -0.65% |
1-year price change | +12.19% |
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations ...
Capitalization | 1 272 M USD |
---|---|
Change | -4.39% |
1-year price change | +22.80% |
Tiansheng Pharmaceutical Group Co LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company's main products include pediatric lung cough particles, erythromycin enteric-coated c ...
Capitalization | 157 M USD |
---|---|
Change | +3.48% |
1-year price change | -30.41% |
4DMedical Limited is an Australia-based medical technology company. Through its flagship patented XV Technology, the Company enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies earlier and with greater sens ...
Capitalization | 176 M USD |
---|---|
Change | +16.10% |
1-year price change | -4.20% |
Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable pl ...
Capitalization | 8 M USD |
---|---|
Change | -6.06% |
1-year price change | -20.51% |
LungLife AI, Inc. is a developer of clinical diagnostic solutions for lung cancer. The Company is engaged in the development and commercialization of its lung cancer early detection test. Using a minimally invasive blood draw, its LungLB test is designed ...
Capitalization | 7 M USD |
---|---|
Change | 0.00% |
1-year price change | -61.96% |
Cizzle Biotechnology Holdings Plc is a United Kingdom-based diagnostics development company. The Company is engaged in the development of a blood test for the early detection of lung cancer. Its prototype test is based on the ability to detect a stable pl ...
Capitalization | 4 M USD |
---|---|
Change | -.--% |
1-year price change | +43.75% |
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Companyâs LungFit platfo ...
Capitalization | 54 M USD |
---|---|
Change | +11.54% |
1-year price change | -33.67% |
Antengene Corporation Limited is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines. The Company is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. T ...
Capitalization | 84 M USD |
---|---|
Change | +1.04% |
1-year price change | -51.50% |
BibbInstruments AB is a Sweden-based medical technology company. It develops and sales biopsy instruments, which are based on technology platform EndoDrill. The drill function enables early cancer diagnosis, especially in deep skin tissues. The portfolio ...
Capitalization | 18 M USD |
---|---|
Change | -1.54% |
1-year price change | +102.53% |
Amoy Diagnostics Co Ltd is a pharmaceutical company engaged in research, development, production and sales of molecular diagnostic products. The Company provides testing reagents and testing services for tumor diagnosis. The Companyâs testing reagent pr ...
Capitalization | 983 M USD |
---|---|
Change | -0.88% |
1-year price change | -17.88% |
Y Biologics Inc is a Korea-based company principally engaged in the new drug development business. The Company is principally engaged in the research and development of new cancer antibody drugs for small cell lung cancer, liver cancer, solid cancer as we ...
Capitalization | 94 M USD |
---|---|
Change | +0.34% |
1-year price change | -43.40% |
Galera Therapeutics, Inc. is a biopharmaceutical company focused on developing a pipeline of novel, therapeutic candidates that have the potential to transform radiotherapy in cancer. The Companyâs lead product candidate, avasopasem manganese (avasopase ...
Capitalization | 6 M USD |
---|---|
Change | -3.67% |
1-year price change | -27.79% |
Gyre Therapeutics, Inc. is a biotechnology company. The Company is engaged in the research, development, manufacturing and commercialization of drugs for organ fibrosis. It is primarily focused on the development and commercialization of Hydronidone (F351 ...
Capitalization | 948 M USD |
---|---|
Change | +2.44% |
1-year price change | -57.80% |
4D Molecular Therapeutics, Inc. is a clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat diseases in ophthalmology and pulmonology. The Company has a portfolio of genetic medicine product candidat ...
Capitalization | 1 175 M USD |
---|---|
Change | -1.80% |
1-year price change | +9.58% |
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonarya ...
Capitalization | 1 052 M USD |
---|---|
Change | -1.42% |
1-year price change | +12.64% |
Prime Medicine, Inc. is a biotechnology company engaged in creating and delivering the gene editing therapies to patients. It deploys its Prime Editing platform, a gene editing technology, to develop a new class of differentiated, one-time genetic therapi ...
Capitalization | 760 M USD |
---|---|
Change | +8.90% |
1-year price change | -20.43% |
AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Its initial candidate is epetraborole, which is a potential onc ...
Capitalization | 61 M USD |
---|---|
Change | -3.94% |
1-year price change | -90.48% |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development ...
Capitalization | 1 410 M USD |
---|---|
Change | -0.29% |
1-year price change | -18.74% |
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic ...
Capitalization | 427 M USD |
---|---|
Change | -1.60% |
1-year price change | -23.22% |
Savara Inc. is a clinical-stage biopharmaceutical company, which is focused on rare respiratory diseases. The Companyâs lead program, molgramostim nebulizer solution (molgramostim), is an inhaled biologic, specifically an inhaled granulocyte-macrophage ...
Capitalization | 547 M USD |
---|---|
Change | +5.93% |
1-year price change | -10.74% |
Aceragen Inc is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious un ...
Capitalization | 3 M USD |
---|---|
Change | +0.58% |
1-year price change | -.--% |
Pulmatrix, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of novel inhaled therapeutic products intended to prevent and treat respiratory and other diseases with important unmet medical needs using its patent ...
Capitalization | 7 M USD |
---|---|
Change | -0.51% |
1-year price change | +5.38% |
Inhibitor Therapeutics, Inc. is a pharmaceutical development company. The Company is focused on developing and commercializing therapeutics based on already approved active pharmaceuticals that have patent-protected methods of use and/or methods of delive ...
Capitalization | 12 M USD |
---|---|
Change | -19.98% |
1-year price change | -23.80% |
Aerovate Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, its dry powde ...
Capitalization | 597 M USD |
---|---|
Change | +5.18% |
1-year price change | -2.08% |
EV Minerals Corporation is a Canadian exploration company focused on mineral exploration and development. The Company focuses on the EV Nickel Project, the host of the nickel-copper-cobalt deposit. The Project comprises approximately 32 mineral claims cov ...
Capitalization | 1 M USD |
---|---|
Change | 0.00% |
1-year price change | -76.47% |
Lung Kee Bermuda Holdings Ltd is an investment holding company principally engaged in the mould base business. The Company is engaged in the manufacture and sale of mould bases and related products. The Company sells its products in China, America, Europe ...
Capitalization | 104 M USD |
---|---|
Change | -1.54% |
1-year price change | -11.72% |
Belluscura PLC is a United Kingdom-based medical device developer company. The Company is focused on developing lightweight and portable oxygen enrichment technology. The Company's product X-PLOR, is a modular portable oxygen concentrator. The X-PLOR is l ...
Capitalization | 26 M USD |
---|---|
Change | 0.00% |
1-year price change | -45.65% |
Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing a portfolio of novel and molecular glue degraders (MGDs) for patients living with serious diseases in the areas of oncology and autoimmune, and m ...
Capitalization | 243 M USD |
---|---|
Change | +1.38% |
1-year price change | -29.20% |
Incannex Healthcare Inc. is a clinical-stage pharmaceutical development company. The Company is developing medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for the treatment of obstructive sleep apnea (OSA), traumatic brain ...
Capitalization | 52 M USD |
---|---|
Change | +0.31% |
1-year price change | -29.74% |
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commerci ...
Capitalization | 2 314 M USD |
---|---|
Change | +0.26% |
1-year price change | +43.80% |
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing servi ...
Capitalization | 792 M USD |
---|---|
Change | -5.39% |
1-year price change | +18.75% |
BioAdaptives, Inc. manufactures and distributes natural plant and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, antiviral activity, and immune system defense; resistance to stress ...
Capitalization | 704 864 USD |
---|---|
Change | 0.00% |
1-year price change | +20.00% |
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a biologic immunomodu ...
Capitalization | 137 M USD |
---|---|
Change | +1.01% |
1-year price change | +40.43% |
Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targetin ...
Capitalization | 80 M USD |
---|---|
Change | +1.59% |
1-year price change | +14.64% |
Bridge Biotherapeutics, Inc. is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The products mainly consist of ulcerative colitis medicine BBT-401, autoxin inhibitor BBT-877, non-small cell lung cancer m ...
Capitalization | 45 M USD |
---|---|
Change | +1.76% |
1-year price change | -20.85% |
Aptamer Sciences Inc is a Korea-based company principally engaged in the research and development of bio therapeutic drugs. The Company provides services include aptamer synthesis and aptamer discovery. The Company also develops biopharmaceuticals such as ...
Capitalization | 35 M USD |
---|---|
Change | -0.70% |
1-year price change | -21.50% |
Kai BioTech Co Ltd is a Korea-based company mainly engaged in the medical business based on radioactive fusion technology. The Company is engaged in the manufacture and sale of radiopharmaceuticals used in the diagnosis of oncology, prostate, liver, lung ...
Capitalization | 5 M USD |
---|---|
Change | -.--% |
1-year price change | -71.18% |
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as t ...
Capitalization | 234 M USD |
---|---|
Change | -5.93% |
1-year price change | +25.00% |
AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The Company's first-in-class ...
Capitalization | 10 M USD |
---|---|
Change | -3.70% |
1-year price change | +8.33% |
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Companyâs technologies are designed to administer disease-fighting genes to provide new therapies for large patient populat ...
Capitalization | 5 M USD |
---|---|
Change | +1.63% |
1-year price change | -72.93% |
Nuvalent, Inc. is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer. It develops small molecules that have the potential to overcome resistance, minimize adverse even ...
Capitalization | 5 112 M USD |
---|---|
Change | +1.19% |
1-year price change | +9.44% |
Tellgen Corp is a company engaged in research, development, production and sales of in vitro diagnostic reagents and instruments. The Company's products are comprised of immunodiagnostic products, molecular diagnostic products and biochemical diagnostic p ...
Capitalization | 268 M USD |
---|---|
Change | +3.02% |
1-year price change | -32.41% |
Betta Pharmaceuticals Co Ltd is a company mainly engaged in research, development, production and sales of innovative drugs for the treatment of malignant tumors. The Company's primary product is its self-developed icotinib hydrochloride (Conmana), a smal ...
Capitalization | 2 132 M USD |
---|---|
Change | -0.73% |
1-year price change | -28.40% |
Gencurix Inc. is a Korea-based company mainly engaged in the sale of medical equipments. In addition, the Company is involved in the manufacturing and sale of breast cancer test (BCT) kits, Korean genetic polymorphism diagnostic kits, lung cancer and colo ...
Capitalization | 31 M USD |
---|---|
Change | 0.00% |
1-year price change | -52.65% |
Lung Hwa Electronics Co., Ltd. is a Taiwan-based company principally engaged in the design, manufacture, processing and distribution of system hosts. The Company mainly provides intelligent home portal security control systems, vehicle multimedia manageme ...
Capitalization | 52 M USD |
---|---|
Change | +0.17% |
1-year price change | -1.49% |
Kwong Lung Enterprise Co., Ltd. is a Taiwan-based company principally engaged in the cleaning and processing of down materials, as well as the processing of garments. The company is also engaged in the manufacture and sales of feather bedding and home tex ...
Capitalization | 283 M USD |
---|---|
Change | +0.83% |
1-year price change | +6.85% |
Hang Lung Properties Limited specializes in promoting and managing real estate assets. The activity is organized around two areas: - real estate leasing; - sale of real estate assets: residential buildings, businesses, offices, hotels, industrial build ...
Capitalization | 4 279 M USD |
---|---|
Change | -0.80% |
1-year price change | -31.71% |
PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary ...
Capitalization | 2 M USD |
---|---|
Change | -5.97% |
1-year price change | +6.52% |
Pharmosa Biopharm Inc is a Taiwan-based company mainly engaged in the research and development of new drugs. The main products include L606, for the treatment of Category I pulmonary arterial hypertension (PAH); L606, for the treatment of Category III pul ...
Capitalization | 289 M USD |
---|---|
Change | -1.36% |
1-year price change | -17.39% |
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The Company is mainly engaged in the research ...
Capitalization | 5 086 M USD |
---|---|
Change | -4.09% |
1-year price change | +73.28% |
Shanghai Yizhong Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development and industrialization of new and improved anti-tumor drugs. The Company's main products include paclitaxel micelles, docetaxel micelles and ...
Capitalization | 691 M USD |
---|---|
Change | +0.62% |
1-year price change | -50.54% |
Hang Lung Group Ltd is an investment holding company principally engaged in the property leasing business. The Company operates its business through two segments. The Property Leasing segments engages in the property leasing operation. The Companyâs inv ...
Capitalization | 1 546 M USD |
---|---|
Change | +0.23% |
1-year price change | -16.64% |
LUNG PIEN VACUUM INDUSTRY CO., LTD. is a Taiwan-based company principally engaged in the manufacture and distribution of photoelectrical machinery. The Company is primarily involved in the provision of optical film coating machines, decorative film coatin ...
Capitalization | 29 M USD |
---|---|
Change | +0.67% |
1-year price change | +8.66% |
FutureChem. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The Company manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer ...
Capitalization | 261 M USD |
---|---|
Change | -3.75% |
1-year price change | +48.25% |
OBI Pharma, Inc. is a Taiwan-based company principally engaged in the development of new pharmaceuticals. The Company mainly operates its businesses through the research and development of novel cancer and infectious disease therapies. It also develops ne ...
Capitalization | 434 M USD |
---|---|
Change | +3.37% |
1-year price change | -11.53% |
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to m ...
Capitalization | 3 504 M USD |
---|---|
Change | -0.92% |
1-year price change | +90.84% |
Shouyao Holdings Co Ltd is a China-based company mainly engaged in the research and development of innovative drugs. The Company's main business is the research and development of small molecule innovative drugs in the clinical stage. The Company's main p ...
Capitalization | 866 M USD |
---|---|
Change | -1.01% |
1-year price change | -23.57% |
Golden Biotechnology Corp is a Taiwan-based company mainly engaged in the development of new anti-cancer drugs. The Company's main development projects are novel compounds of Antroquinonol for the treatment of non-small cell lung cancer, acute myeloid leu ...
Capitalization | 88 M USD |
---|---|
Change | -4.74% |
1-year price change | -48.79% |
Urteste SA is a Poland-based company mainly engaged in the biotechnology sector. The Company operates in the field of medical devices for in vitro application in the field of cancer diagnostics. The technology developed by the Company involves the detecti ...
Capitalization | 33 M USD |
---|---|
Change | -0.21% |
1-year price change | -13.94% |
Gongwin Biopharm Holdings Co Ltd is a company engaged in the research and development of anti-cancer medicine, especially focuses on the precise treatment to tumors. The Companyâs headquarter is located in Taiwan and it created a cross-regional platform ...
Capitalization | 561 M USD |
---|---|
Change | +0.63% |
1-year price change | -13.01% |
Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the research, development and marketing of cryoablation systems, disposables and technolog ...
Capitalization | 35 M USD |
---|---|
Change | +0.26% |
1-year price change | -28.97% |
Genomictree Inc. is a Korea-based company mainly engaged in the genomic analysis. The Company is involved in conducting of genomic analysis using microarrays and next generation sequencing analysis. In addition, the Company is conducting clinical trials f ...
Capitalization | 357 M USD |
---|---|
Change | -2.44% |
1-year price change | -2.91% |
Original BioMedicals Co Ltd is a Taiwan-based company mainly engaged in the development of new drugs with non-new ingredients, and the provision of related research and development services, especially focusing on drugs with new dosage forms, new dosages, ...
Capitalization | 32 M USD |
---|---|
Change | -0.93% |
1-year price change | -12.15% |
Oryzon Genomics SA, is a Spain-based clinical phase biopharmaceutical company, which discovers and develops drugs based on epigenetics for the treatment of oncological and neurological diseases. Its compounds in clinical development include iadademstat (O ...
Capitalization | 124 M USD |
---|---|
Change | -1.81% |
1-year price change | +3.28% |
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using deoxyribonucleic acid (DNA) methylation technology. It develops and commercializes blood-based diagnostic products ...
Capitalization | 1 M USD |
---|---|
Change | 0.00% |
1-year price change | -18.52% |
Oncology Pharma, Inc. is an oncology company. The Company is focused on licensing, developing, manufacturing and commercializing therapeutics. The Companyâs research, development, and commercialization of therapeutic drugs and medical devices designed f ...
Capitalization | 3 866 USD |
---|---|
Change | -99.00% |
1-year price change | -50.00% |
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based company mainly engaged in the production, sales and service of chemical raw materials and intermediates. The Company is committed to providing one-stop customized pharmaceutical contract development ...
Capitalization | 1 808 M USD |
---|---|
Change | +0.21% |
1-year price change | -39.82% |
Nascent Biotech, Inc. is a phase II clinical-stage biopharmaceutical company engaged in developing monoclonal antibodies for the treatment of various cancer types. The Company focuses on biologic drug candidates that are undergoing or have already complet ...
Capitalization | 14 M USD |
---|---|
Change | -1.13% |
1-year price change | -54.31% |
Delta-Fly Pharma, Inc. is a Japan-based company principally engaged in the research, development, manufacture and sale of pharmaceuticals. The Company's development pipeline includes anticancer drug candidate compound DFP-10917 whose target disease is ref ...
Capitalization | 28 M USD |
---|---|
Change | +2.97% |
1-year price change | -45.42% |
Beta Drugs Limited is an India-based company, which is engaged in manufacturing of the wide range of anti-cancer drugs in India. The Company operates through manufacturing of Oncology medicines segment. The Company offers a portfolio consisting of approxi ...
Capitalization | 146 M USD |
---|---|
Change | -1.65% |
1-year price change | -14.90% |
PT Royal Prima Tbk is an Indonesia-based healthcare services company. The Company provides hospital services, clinics, polyclinics and related business activities. The Company operates Royal Prima Medan and Royal Prima Jamb hospital. The Company provides ...
Capitalization | 14 M USD |
---|---|
Change | -7.58% |
1-year price change | -30.68% |
Shanghai Allist Pharmaceuticals Co Ltd is a China-based company focusing on the field of tumor treatment. The Company has built a research and development pipeline in the field of small molecule targeted drugs for non-small cell lung cancer. The Company h ...
Capitalization | 3 844 M USD |
---|---|
Change | -2.60% |
1-year price change | +48.58% |
FluoGuide A/S is a Denmark-based biotechnology company focused on developing drugs for maximizing surgical outcomes by making cancer fluorescent. The Company is a provider of solutions for maximizing surgical outcome through intelligent targeting. FluoGui ...
Capitalization | 55 M USD |
---|---|
Change | -2.62% |
1-year price change | -24.10% |
Amniotics AB (publ) is a Sweden-based biotech company that develops cell therapy drugs based on mesenchymal stem cells from amniotic fluid in its in-house GMP licensed facility. Amniotics' own marker technology is used to identify and select stem cells fo ...
Capitalization | 1 M USD |
---|---|
Change | -9.52% |
1-year price change | -57.78% |
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Companyâs primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles ...
Capitalization | 6 M USD |
---|---|
Change | +6.90% |
1-year price change | +7.43% |
Spexis AG, former Polyphor AG, is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of first-in-class molecules in oncology and antimicrobial resistance leveraging its macrocyclic peptide te ...
Capitalization | 4 M USD |
---|---|
Change | -15.25% |
1-year price change | +21.95% |
Hainan Huluwa Pharmaceutical Group Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of Chinese patent medicines and chemical drugs. Its products are used in the pharmaceutical fields of respirat ...
Capitalization | 570 M USD |
---|---|
Change | +1.97% |
1-year price change | -31.86% |
Artemis Medicare Services Ltd, also known as Artemis Hospitals, is an India-based company, which operates a multi-specialty hospital. The Company is specializes in a range of advanced medical and surgical interventions, a mix of inpatient and outpatient s ...
Capitalization | 287 M USD |
---|---|
Change | +2.73% |
1-year price change | -0.07% |
Nextage Therapeutics Ltd, formerly known asMicromedic Technologies Ltd,is an Israel-based company engaged in the development and commercialization of cancer diagnostic products. Its portfolio includes a range of cancer and cancer-related indications inclu ...
Capitalization | 7 M USD |
---|---|
Change | -1.98% |
1-year price change | +122.09% |
Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing transformative therapies for rare and neurological diseases with limited treatment options. The Companyâs Trappsol Cyclo is a proprietary formulatio ...
Capitalization | 36 M USD |
---|---|
Change | +0.40% |
1-year price change | -21.38% |
Alteco Medical AB is a Sweden-based company engaged in the healthcare and biotechnology business sector. The Company develops medical devices focusing on intensive care. The Companyâs product named Alteco LPS Adsorber is used within the sepsis area and ...
Capitalization | 678 226 USD |
---|---|
Change | -1.57% |
1-year price change | -64.29% |
Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological products. Its activities are involved in a range of areas: oncology, infections an ...
Capitalization | 38 M USD |
---|---|
Change | -0.40% |
1-year price change | -11.90% |
Polaris Group is a Cayman Islands-based biopharmaceutical company, which is engaged in advanced therapies, primarily focusing on metabolic related diseases. The Companyâs drug candidate, Pegargiminase (ADI-PEG 20), is advancing through the biologics lic ...
Capitalization | 1 680 M USD |
---|---|
Change | -0.41% |
1-year price change | -3.04% |
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, Neuromodulation and Advanced Circulatory Support (ACS). Cardiopulmonary segment is e ...
Capitalization | 2 891 M USD |
---|---|
Change | -0.21% |
1-year price change | +3.02% |
Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods ...
Capitalization | 1 361 M USD |
---|---|
Change | -1.76% |
1-year price change | +35.81% |
NGeneBio Co Ltd is a Korea-based company engaged in the manufacture and sale of precision diagnostic products. The Company's main products include BRCAaccuTest products used for hereditary breast and ovarian cancer testing, HEMEaccuTest products that test ...
Capitalization | 31 M USD |
---|---|
Change | -1.19% |
1-year price change | -40.29% |
- Stock Market
- Advanced search
- Kwok Lung Hongchoy
- Company Profiles